Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation

In favor of their outgrowth, cancer cells must resist immune surveillance and edit the immune response. Cancer immunoediting is characterized by fundamental changes in the cellular composition and the inflammatory cytokine profiles in the microenvironment of the primary tumor and metastatic niches,...

Descripción completa

Detalles Bibliográficos
Autores principales: Greil, Richard, Hutterer, Evelyn, Hartmann, Tanja Nicole, Pleyer, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244547/
https://www.ncbi.nlm.nih.gov/pubmed/28100240
http://dx.doi.org/10.1186/s12964-016-0155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244547/
https://www.ncbi.nlm.nih.gov/pubmed/28100240
http://dx.doi.org/10.1186/s12964-016-0155-9

Ejemplares similares